IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 7,700.00
-40.00 (-0.52%)
Aug 8, 2025, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 107.94 billion as of August 8, 2025. Its market cap has decreased by -9.52% in one year.
Market Cap
107.94B
Enterprise Value
81.55B
Revenue
3.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,700.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 107.94B, a decrease of -78.57%. That is a compound annual growth rate of -68.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 108.50B | -27.32% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.80T |
| Celltrion | 39.35T |
| ALTEOGEN | 23.73T |
| SK Biopharmaceuticals | 8,724.10B |
| Yuhan | 8,599.10B |
| Peptron | 6,872.72B |
| HLB Co., Ltd. | 6,237.58B |
| PharmaResearch | 5,859.76B |